[Corrigendum] A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first

Abstract

Figures

A](#f1-ol-31-5-15526), is shown on the next page. The authors regret that this error went unnoticed before this article was published, although note that it did not grossly affect either the results or the conclusions reported in this article. All the authors agree with the publication of this Corrigendum, and thank the Editor of *Oncology Letters* for granting them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.

Full text

Oncol Rep 6: 393–400, 2013; DOI: 10.3892/ol.2013.1380

Following the publication of the above paper, an interested reader drew to the authors’ attention that, regarding the PCR analysis of clinical ovarian cancer tissues shown in Fig. 1A on p. 396, the GAPDH data [for the normal (N) and cancer (C) tissues] for RT-PCR samples #15 and #24 were strikingly similar, suggesting that an error had been made during the assembly of this figure.

Upon assessing their data, the authors realized that the correct GAPDH data for RT-PCR sample #15 had inadvertently been reinserted into the figure for RT-PCR sample #24. The revised version of Fig. 1, now showing the correct GAPDH data for RT-PCR sample #24 in Fig. 1A, is shown on the next page. The authors regret that this error went unnoticed before this article was published, although note that it did not grossly affect either the results or the conclusions reported in this article. All the authors agree with the publication of this Corrigendum, and thank the Editor of Oncology Letters for granting them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.